Notice of Correction to the Open Date (Earliest Submission Date) of PAR-21-247, “Technology Development for Single-Molecule Protein Sequencing (R43/R44 Clinical Trial not allowed)”
Notice Number:
NOT-HG-21-043

Key Dates

Release Date:

August 19, 2021

Related Announcements

PAR-21-247 - Technology Development for Single-Molecule Protein Sequencing (R43/R44 Clinical Trial not allowed)

RFA-HG-21-001 - Technology Development for Single-Molecule Protein Sequencing and Single-Cell Proteome Analysis (R01 Clinical Trial not allowed)

RFA-HG-21-002 - Technology Development for Single-Molecule Protein Sequencing (R21 Clinical Trial not allowed)

Issued by

National Human Genome Research Institute (NHGRI)

Purpose

The purpose of this Notice is to inform applicants of a correction to the Open Date (Earliest Submission Date) for Funding Opportunity Announcement (FOA) PAR-21-247, “Technology Development for Single-Molecule Protein Sequencing (R01 Clinical Trial not allowed)". This FOAhas been changed to show that the first Open Date for application submission is September 1, 2021.

The following section of PAR-21-247 has been modified:

Currently Reads:

Key Dates

Posted Date

July 9, 2021

Open Date (Earliest Submission Date)

October 1, 2021

Letter of Intent Due Date(s)

30 days prior to the application due date

Application Due Date(s)

October 1, 2021; June 15, 2022; June 15, 2023

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Application Due Date(s)

Not Applicable

Scientific Merit Review

February/March 2022; October/November 2022; October/November 2023

Advisory Council Review

May 2022; February 2023; February 2024

Earliest Start Date

August 2022; May 2023; May 2024

Expiration Date

June 16, 2023

Due Dates for E.O. 12372

Not Applicable

Modified to Read (change shown in bold italics):

Key Dates

Posted Date

July 9, 2021

Open Date (Earliest Submission Date)

September 1, 2021

Letter of Intent Due Date(s)

30 days prior to the application due date

Application Due Date(s)

October 1, 2021; June 15, 2022; June 15, 2023

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Application Due Date(s)

Not Applicable

Scientific Merit Review

February/March 2022; October/November 2022; October/November 2023

Advisory Council Review

May 2022; February 2023; February 2024

Earliest Start Date

August 2022; May 2023; May 2024

Expiration Date

June 16, 2023

Due Dates for E.O. 12372

Not Applicable

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Tina Gatlin, Ph.D.
National Human Genome Research Institute (NHGRI)
Telephone: 301-480-2280
Email: gatlincl@nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices